Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients

被引:1
作者
Najmadini, Atefeh [1 ]
Mohammadi, Mohammad Mahdi [1 ]
Langroudi, Ladan [1 ]
Meimand, Hosseinali Ebrahimi [2 ]
Mahmoodi, Merat [1 ]
Mirzaei, Moghadameh [3 ]
机构
[1] Kerman Univ Med Sci, Sch Med, Dept Med Immunol, Kerman, Iran
[2] Kerman Univ Med Sci, Shafa Hosp, Neurol Res Ctr, Dept Neurol,Sch Med, Kerman, Iran
[3] Kerman Univ Med Sci, Modeling Hlth Res Ctr, Inst Futures Studies Hlth, Kerman, Iran
关键词
Multiple sclerosis; Epstein-Barr virus; T cell exhaustion; PD-1; EPSTEIN-BARR-VIRUS; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; INFECTION; DEFICIENCY; EXHAUSTION; RISK; AGE;
D O I
10.1007/s13365-022-01083-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple sclerosis (MS) is one of the common autoimmune diseases. The exact etiology of MS is still unclear, but recent studies have shown the possibility of infectious agent involvement such as Epstein-Barr virus (EBV) in MS pathophysiology. In this study, CD3 (+) CD8 (+) T cells of 25 new case MS patients were compared with healthy donors for expression of exhaustion marker, PD-1, using flow cytometry. Also, the expression of the EBV gene, BRCF-1, in PBMCs was analyzed using real-time PCR. Results revealed a lower frequency of CD3 (+) CD8 (+) T cells in MS patients. Also, increased expression of PD-1 was observed on CTLs which correlated with higher viral loads. Therefore, a lower frequency of CD8 (+) T cells but a higher exhaustion marker in MS patients reveals a new mechanism of EBV pathogenesis in MS development. The results suggest that inefficient immune control of EBV in patients with MS may cause exacerbation of the disease. Future studies on the mechanism of T cell exhaustion and chronic infections may aid in a better understanding of the disease and the design of effective therapies.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 52 条
  • [1] Abdollahi M, 2016, J MAZ U MED SCI, V26, P71
  • [2] Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis
    Abrahamyan, Sargis
    Eberspaecher, Bettina
    Hoshi, Muna-Miriam
    Aly, Lilian
    Luessi, Felix
    Groppa, Sergiu
    Klotz, Luisa
    Meuth, Sven G.
    Schroeder, Christoph
    Grueter, Thomas
    Tackenberg, Bjoern
    Paul, Friedemann
    Then-Bergh, Florian
    Kuempfel, Tania
    Weber, Frank
    Stangel, Martin
    Bayas, Antonios
    Wildemann, Brigitte
    Heesen, Christoph
    Zettl, Uwe
    Warnke, Clemens
    Antony, Gisela
    Hessler, Nicole
    Wiendl, Heinz
    Bittner, Stefan
    Hemmer, Bernhard
    Gold, Ralf
    Salmen, Anke
    Ruprecht, Klemens
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (07) : 681 - 686
  • [3] HLA alleles modulate EBV viral load in multiple sclerosis
    Agostini, Simone
    Mancuso, Roberta
    Guerini, Franca R.
    D'Alfonso, Sandra
    Agliardi, Cristina
    Hernis, Ambra
    Zanzottera, Milena
    Barizzone, Nadia
    Leone, Maurizio A.
    Caputo, Domenico
    Rovaris, Marco
    Clerici, Mario
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [4] Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
    Ascherio, A
    Munger, KL
    Lennette, ET
    Spiegelman, D
    Hernán, MA
    Olek, MJ
    Hankinson, SE
    Hunter, DJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (24): : 3083 - 3088
  • [5] Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans
    Ayee, Richmond
    Ofori, Maame Ekua Oforiwaa
    Wright, Edward
    Quaye, Osbourne
    [J]. JOURNAL OF CANCER, 2020, 11 (07): : 1737 - 1750
  • [6] Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition
    Balfour, Henry H., Jr.
    Sifakis, Frangiscos
    Sliman, Joseph A.
    Knight, Jennifer A.
    Schmeling, David O.
    Thomas, William
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (08) : 1286 - 1293
  • [7] Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
    Bar-Or, Amit
    Pender, Michael P.
    Khanna, Rajiv
    Steinman, Lawrence
    Hartung, Hans-Peter
    Maniar, Tap
    Croze, Ed
    Aftab, Blake T.
    Giovannoni, Gavin
    Joshi, Manher J.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2020, 26 (03) : 296 - 310
  • [8] A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS
    Bech, E
    Lycke, J
    Gadeberg, P
    Hansen, HJ
    Malmeström, C
    Andersen, O
    Christensen, T
    Ekholm, S
    Haahr, S
    Höllsberg, P
    Bergström, T
    Svennerholm, B
    Jakobsen, J
    [J]. NEUROLOGY, 2002, 58 (01) : 31 - 36
  • [9] Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
    Bjornevik, Kjetil
    Cortese, Marianna
    Healy, Brian C.
    Kuhle, Jens
    Mina, Michael J.
    Leng, Yumei
    Elledge, Stephen J.
    Niebuhr, David W.
    Scher, Ann, I
    Munger, Kassandra L.
    Ascherio, Alberto
    [J]. SCIENCE, 2022, 375 (6578) : 296 - +
  • [10] Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus
    Cencioni, Maria T.
    Magliozzi, Roberta
    Nicholas, Richard
    Ali, Rehiana
    Malik, Omar
    Reynolds, Richard
    Borsellino, Giovanna
    Battistini, Luca
    Muraro, Paolo A.
    [J]. IMMUNOLOGY, 2017, 152 (04) : 660 - 676